ArticleNuclear medicine communications2025
Clinical phenotypes among patients that underwent cardiac resynchronization therapy using unsupervised learning integrating gated SPECT.
Article in Nuclear medicine communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCardiac resynchronization therapy (CRT) is an effective treatment for heart failure when left ventricular mechanical dyssynchrony (LVdys) is present, yet approximately 30-40% of patients do not respond to therapy. The purpose of this study is to use unsupervised learning to identify phenotypes of patients with a better response rate.
methodsUnsupervised learning integrating gated single-photon emission computed tomography (SPECT) was used to identify clinical phenotypes among patients undergoing CRT. We utilized hierarchical clustering analysis to group 217 patients based on 49 pretreatment variables, including demographic, clinical, and phase analysis of gated SPECT data. Fibrosis was measured by the percentage of pixels with less than 50% of maximum relative counts. LVdys was evaluated by phase SD >43° and phase bandwidth >135°.
resultsWe identified three phenotypes of patients: two with similar response rates (86.2 and 87.0%) but with different characteristics, one presenting borderline LVdys, low fibrosis and nondilated heart and the other high LVdys, moderate fibrosis and a dilated heart; the third phenotype represents patients with moderate LVdys, substantial amounts of cardiac fibrosis and a dilated heart that do not have a good response to CRT (55.9%).
conclusionOur results suggest that evaluating cardiac dyssynchrony, fibrosis, and remodeling through phase analysis of gated SPECT is relevant in characterizing the phenotype of good responders. Patients with substantial amounts of cardiac fibrosis have less benefit from CRT. This work suggests that CRT recommendations based on customized selection criteria associated with gated SPECT can lead to higher response rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.